Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Polymorphisms in the TAFI Gene and the Risk of Venous Thrombosis

Kostka, H.; Kuhlisch, E.; Schellong, S.; Siegert, G.

Clinical Laboratory 49(11-12): 645-647

2003

ISSN/ISBN: 1433-6510
PMID: 14651335
Document Number: 9631
Thrombin-activable fibrinolysis inhibitor (TAFI) is a recently described inhibitor of fibrinolysis. The aim of this study was to estimate the risk of deep venous thrombosis (DVT) caused by the polymorphisms in the TAFI gene in relation to polymorphisms of the other fibrinolytic variables such as PAI-844A>G and t-PA-7,351C>T. This study includes 130 patients with DVT and 130 age- and sex-matched healthy controls. Our results showed no association of the investigated "TAFI-increasing" alleles TAFI 505A (Thr147) and TAFI+1542C with the risk of venous thrombosis. However the adjustment for age, sex, factor V Leiden, PAI -844A allele and t-PA-7,351T allele indicates a tendency to a moderately increased thrombotic risk of TAFI+1542GG carriers (low TAFI level).

Document emailed within 1 workday
Secure & encrypted payments

Polymorphisms in the TAFI Gene and the Risk of Venous Thrombosis

Reuner, K.H.; Ruf, A.; Grau, A.; Rickmann, H.; Stolz, E.; Jüttler, E.; Druschky, K.F.; Patscheke, H. 1998: Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis Stroke 29(9): 1765-1769
Koopman, K.; Uyttenboogaart, M.; Vroomen, P.C.A.J.; van der Meer, J.; De Keyser, J.; Luijckx, G-Jan. 2009: Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years Thrombosis and haemostasis 102(4): 620-622
Kleesiek, K.; Schmidt, M.; Götting, C.; Schwenz, B.; Lange, S.; Müller-Berghaus, G.; Brinkmann, T.; Prohaska, W. 1999: The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis Thrombosis and Haemostasis 82(1): 1-5
Martinelli, I.; Landi, G.; Merati, G.; Cella, R.; Tosetto, A.; Mannucci, P.M. 1996: Factor V gene mutation is a risk factor for cerebral venous thrombosis Thrombosis and Haemostasis 75(3): 393-394
Baturin, A.K.; Sorokina, E.Y.; Pogozheva, A.V.; Peskova, E.V.; Makurina, O.N.; Tutelyan, V.A. 2016: The investigation the combined effect of SNP rs9939609 (gene FTO) and rs4994 (gene ADRB3) polymorphisms on risk of obesity Voprosy Pitaniia 85(4): 29-34
Rosendaal, F.R. 1997: Thrombosis in the young: epidemiology and risk factors. a focus on venous thrombosis Thrombosis and Haemostasis 78(1): 1-6
Schroeder, V.; Wilmer, M.; Buehler, B.; Kohler, H.P. 2006: TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays Thrombosis and Haemostasis 96(2): 236-237
Li, Y.; Chen, F.; Zhou, L.; Coulter, D.; Chen, C.; Sun, Z.; Chen, J.; Pan, H.; Wu, Y.; Zhou, J.; Ba, L.; Zhao, J.; Shen, H. 2010: COC use, ACE/AGT gene polymorphisms, and risk of stroke Pharmacogenetics and Genomics 20(5): 298-306
Rosendaal, F.R. 1997: Risk factors for venous thrombosis: prevalence, risk, and interaction Seminars in Hematology 34(3): 171-187
Prountjos, P.; Bastounis, E.; Hadjinikolaou, L.; Felekuras, E.; Balas, P. 1991: Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. a phlebographic study on 57 cases International Angiology: a Journal of the International Union of Angiology 10(2): 63-65
Mendonça, M.I.; Dos Reis, R.P.; Freitas, A.I.; Sousa, A.C.; Pereira, A.; Faria, P.; Gomes, S.; Silva, B.; Santos, N.; Serrão, M.; Ornelas, I.íd.; Freitas, S.ón.; Araújo, J.é J.; Brehm, A.ón.; Cardoso, A.A. 2008: Human paraoxonase gene polymorphisms and coronary artery disease risk Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 27(12): 1539-1555
Bogdanovic, L.; Lazic, M.; Bogdanovic, J.; Soldatovic, I.; Nikolic, N.đa.; Radunovic, M.; Radojevic-Skodric, S.; Milasin, J.; Basta-Jovanovic, G. 2017: Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population Journal of Buon: Official Journal of the Balkan Union of Oncology 22(1): 270-277
Zhang, C.; Guo, L. 2015: Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease Wei Sheng Yan Jiu 44(5): 730-737
Drysdale, H.C. 1995: Flight and risk of venous thrombosis Aviation Space and Environmental Medicine 66(3): 283
Drysdale, H.C. 1995: Flight and risk of venous thrombosis Aviation Space and Environmental Medicine 66(3): 283
Khadzhieva, M.B.; Kamoeva, S.V.; Ivanova, A.V.; Abilev, S.K.; Salnikova, L.E. 2015: Elastogenesis-Related Gene Polymorphisms and the Risk of Pelvic Organ Prolapse Development Genetika 51(10): 1191-1198
Małodobra-Mazur, Młgorzata.; Paduch, A.; Lebioda, A.; Konopacka, M.; Rogoliński, J.; Szymczyk, C.; Wierzgoń, J.; Maciejewski, A.; Chmielik, E.; Jonkisz, A.; Półtorak, Sław.; Dobosz, T. 2012: VDR gene single nucleotide polymorphisms and their association with risk of oral cavity carcinoma Acta Biochimica Polonica 59(4): 627-630
Chou, H-Tai.; Shi, Y-Ru.; Hsu, Y.; Tsai, F-Jen. 2003: Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse Journal of Heart Valve Disease 12(4): 475-481
Wang, H-Chung.; Chiu, C-Fang.; Tsai, R-Yin.; Kuo, Y-Shun.; Chen, H-Shiang.; Wang, R-Fen.; Tsai, C-Wen.; Chang, C-Hsiang.; Lin, C-Chieh.; Bau, D-Tian. 2009: Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan Anticancer Research 29(10): 3897-3901
Zuazu-Jausoro, I.; Sanchez, I.; Fernandez, M.C.; Corral, J.; Gonzalez-Conejero, R.; Vicente, V. 1998: Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 a allele of the prothrombin gene Haematologica 83(12): 1129-1130